ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,222.68
0.16%
US Tech 100
17,650.00
0.05%
다우존스 지수
39,512.84
0.32%
Bitcoin
61,297.81
0.82%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Innoviva Inc (INVA)

  7. Innoviva Inc (INVA) 뉴스

INVA

Innoviva (INVA)

Innoviva Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:INVA
일자시간출처헤드라인심볼기업
2024/05/0905:46Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INVAInnoviva Inc
2024/05/0905:44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVAInnoviva Inc
2024/05/0905:05Business WireInnoviva Reports First Quarter 2024 Financial Results; Highlights Recent Company ProgressNASDAQ:INVAInnoviva Inc
2024/05/0820:00Business WireInnoviva to Participate in the BofA Securities Health Care ConferenceNASDAQ:INVAInnoviva Inc
2024/04/2420:00Business WireInnoviva Specialty Therapeutics’ Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024NASDAQ:INVAInnoviva Inc
2024/03/0809:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
2024/03/0809:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
2024/03/0809:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
2024/03/0808:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
2024/03/0107:01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:INVAInnoviva Inc
2024/03/0106:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVAInnoviva Inc
2024/03/0106:05Business WireInnoviva Reports Fourth Quarter and Full Year 2023 Financial Results; Highlights Recent Company ProgressNASDAQ:INVAInnoviva Inc
2024/02/2311:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
2024/02/2311:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
2024/02/1421:23Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INVAInnoviva Inc
2024/01/2311:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
2024/01/2304:03Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INVAInnoviva Inc
2024/01/1110:26Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
2023/11/1806:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
2023/11/0622:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVAInnoviva Inc
2023/11/0205:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INVAInnoviva Inc
2023/11/0205:15Business WireInnoviva Reports Third Quarter 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:INVAInnoviva Inc
2023/11/0205:05Business WirePositive Results Announced in Largest Pivotal Phase 3 Trial of a First-in-Class Oral Antibiotic to Treat Uncomplicated GonorrheaNASDAQ:INVAInnoviva Inc
2023/09/1921:30Business WireInnoviva to Participate in the Cantor Global Healthcare ConferenceNASDAQ:INVAInnoviva Inc
2023/09/1821:00Business WireXACDURO®, The First and Only Antibiotic Developed to Target Acinetobacter, Now Available to Treat Hospital-Acquired Bacterial Pneumonia (HABP) and Ventilator-Associated Bacterial Pneumonia (VABP) in AdultsNASDAQ:INVAInnoviva Inc
2023/09/0109:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
2023/09/0109:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
2023/09/0109:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
2023/09/0109:10Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
2023/09/0109:10Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:INVAInnoviva Inc
 검색 관련기사 보기:NASDAQ:INVA

최근 히스토리

NYSE
MRK
Merck
NYSE
BAC
Bank of America
NYSE
DIS
Walt Disney
NASDAQ
MSFT
Microsoft
AMEX
XLF
Financial Select Sector
USI
USTECH100
US Tech 100
NYSE
XOM
Exxon Mobil
NYSE
AXP
American Express
NASDAQ
AMZN
Amazon.com
COIN
SOLUSD
Solana
CCOM
US500
US 500
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
NKE
Nike
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
SPY
SPDR S&P 500
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유